secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oaktree Acquisition Corp. III Life Sciences (OACC)
CIK:        0002029769
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001193125-24-248669
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oaktree Acquisition Corp. III Life Sciences completes $175M IPO, funds placed in trust for acquisition
--------------------------------------------------------------------------------

- Completed IPO of 17,500,000 units at $10.00 per unit, generating gross proceeds of $175,000,000.
- Private placement of 550,000 units to sponsor at $10.00 per unit, gross proceeds $5,500,000.
- Net proceeds $175,000,000 placed in trust account for benefit of public shareholders.
- On Oct 30, partial over-allotment exercise: 1,699,029 units ($16,990,290); sponsor bought 33,981 private placement units ($339,810).
- Audited balance sheet as of Oct 25, 2024 shows $177.1M total assets, $175M in trust, shareholders' deficit of $(5.5M).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2029769/000119312524248669/0001193125-24-248669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2029769/000119312524248669/d873991d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-248669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer